Nonlawat Boonyalai

50, Phahon Yothin Road
Chatuchak, 10900, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Using Unbiased Chemical Proteomics Approaches to Explore the Target Landscape of the Resistance Refractory 7-Azaindole MMV022224 in Plasmodium falciparum.

Using Unbiased Chemical Proteomics Approaches to Explore the Target Landscape of the Resistance Refractory 7-Azaindole MMV022224 in Plasmodium falciparum.

Journal: ACS infectious diseases

Published: June 25, 2026

Potent reaction hijacking inhibitors of Plasmodium falciparum asparagine tRNA synthetase.

Potent reaction hijacking inhibitors of Plasmodium falciparum asparagine tRNA synthetase.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

Potent reaction hijacking inhibitors of Plasmodium falciparum asparagine tRNA synthetase.

Potent reaction hijacking inhibitors of Plasmodium falciparum asparagine tRNA synthetase.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

Protein Arginine Methyltransferase Inhibitors Target Multiple Stages of Plasmodium falciparum Parasites In Vitro.

Protein Arginine Methyltransferase Inhibitors Target Multiple Stages of Plasmodium falciparum Parasites In Vitro.

Journal: ACS infectious diseases

Published: March 31, 2026

Mechanistic insights into dual-active liver and blood-stage antiplasmodials.

Mechanistic insights into dual-active liver and blood-stage antiplasmodials.

Journal: mBio

Published: November 24, 2025

Shared Binding Site but Divergent Resistance Profiles Uncover Novel Resistance Mechanisms in Plasmodium HSP90 Inhibitors.

Shared Binding Site but Divergent Resistance Profiles Uncover Novel Resistance Mechanisms in Plasmodium HSP90 Inhibitors.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Plasmodium falciparum HSP90 inhibitors show divergent resistance despite a shared ATP-binding site.

Plasmodium falciparum HSP90 inhibitors show divergent resistance despite a shared ATP-binding site.

Journal: Cell reports

Published: November 03, 2025

Preclinical in vitro and in vivo evaluation of omadacycline against multidrug-resistant Acinetobacter baumannii.

Preclinical in vitro and in vivo evaluation of omadacycline against multidrug-resistant Acinetobacter baumannii.

Journal: Antimicrobial agents and chemotherapy

Published: October 30, 2025

Optimization of 2,8-Diaryl-1,5-naphthyridines as Plasmodium falciparum Phosphatidylinositol 4-Kinase Inhibitors with Improved ADME Profiles and In Vivo Efficacy.

Optimization of 2,8-Diaryl-1,5-naphthyridines as Plasmodium falciparum Phosphatidylinositol 4-Kinase Inhibitors with Improved ADME Profiles and In Vivo Efficacy.

Journal: Journal of medicinal chemistry

Published: October 07, 2025

Targeting Aurora Kinases as Essential Cell-Cycle Regulators to Deliver Multi-Stage Antimalarials Against Plasmodium Falciparum.

Targeting Aurora Kinases as Essential Cell-Cycle Regulators to Deliver Multi-Stage Antimalarials Against Plasmodium Falciparum.

Journal: Angewandte Chemie (International ed. in English)

Published: August 22, 2025

Novel Inhibitors of Plasmodium Phosphatidylinositol 4-kinase IIIβ with Low Propensity for Resistance: Life Cycle Stage Activity and In Vivo Efficacy in a Humanized Mouse Malaria Infection Model.

Novel Inhibitors of Plasmodium Phosphatidylinositol 4-kinase IIIβ with Low Propensity for Resistance: Life Cycle Stage Activity and In Vivo Efficacy in a Humanized Mouse Malaria Infection Model.

Journal: Journal of medicinal chemistry

Published: August 14, 2025

Mechanistic Insights into Dual-Active Liver and Blood-Stage Antiplasmodials.

Mechanistic Insights into Dual-Active Liver and Blood-Stage Antiplasmodials.

Journal: bioRxiv : the preprint server for biology

Published: August 13, 2025

Showing 1-12 of 33

Last Updated: 09/26/2026